Drug profile · INN
tetrabenazine
INOVA PHARMACEUTICALS (AUSTRALIA) PTY LTD
tetrabenazine (INOVA PHARMACEUTICALS (AUSTRALIA) PTY LTD) is a synaptic vesicular amine transporter inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — tetrabenazine
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 7
- Data quality
- 0.84
Quick answer
tetrabenazine (INOVA PHARMACEUTICALS (AUSTRALIA) PTY LTD) is a synaptic vesicular amine transporter inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Synaptic vesicular amine transporter inhibitor
Primary target: Synaptic vesicular amine transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is tetrabenazine?
tetrabenazine (INOVA PHARMACEUTICALS (AUSTRALIA) PTY LTD) is a synaptic vesicular amine transporter inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tetrabenazine?
INOVA PHARMACEUTICALS (AUSTRALIA) PTY LTD is a marketed brand name for tetrabenazine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tetrabenazine?
tetrabenazine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.